- Search results for 18642-23-4
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "18642-23-4"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T3399-100mg
Description: Psoralidin inhibits Akt phosphorylation and phosphatidylinositol 3-kinase activation and transcriptionally. Psoralidin possesses anticancer and chemopreventive properties. Target: Reactive Oxygen Species, Antibacterial, Akt, COX, Estrogen/progestogen Receptor, Lipoxygenase, Gamma-secretase,...
CAS | 18642-23-4 |
MW: | 336.34 D |
From 57.00€
*
Item number: Cay15119-10
Psoralidin is a furanocoumarin isolated from the seeds of P. corylifolia, a medicinal plant found in southeastern Asia, that has been shown to induce cytotoxicity against various cancer cells. Through TNF-related apoptosis-inducing ligand-mediated events, psoralidin at 50 µM can induce the death of HeLa cancer...
Keywords: | 3,9-dihydroxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one |
Application: | Apoptosis inducer |
CAS | 18642-23-4 |
MW: | 336.3 D |
From 133.00€
*
Item number: LKT-P7359.10
Psoralidin inhibits forskolin-induced corticotrophin releasing factor gene transcription. Recently, it has shown activity in vitro against gastric, colon, prostate, and breast cancer lines. It has the capability to inhibit protein tyrosine phosphatase 1B, a key metabolite involved in insulin signaling
CAS | 18642-23-4 |
MW: | 336,34 D |
From 244.00€
*